SPOTLIGHT: Minerva Biotechnologies fires CEO


Massachusetts-based nanotech firm Minerva Biotechnologies is on the hunt for a new CEO after firing Jim Czirr. Reasons for the termination were not revealed, but the company says it has brought suit against Czirr in Massachusetts Superior Court. Release

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.